Inventor · disambiguated record
Mark D. Mannie
Also filed as: MANNIE MARK D · MANNIE MARK DAVID
7 granted patents·4 pending applications·8 citations·filing 2007–2022
78Inventor score
Top patents by PatentIndex Score
11 records- 0176US10273284B2Cytokine-based fusion proteins for treatment of immune disordersUNIV EAST CAROLINA·Filed 2017·Granted Apr 30, 2019·2 cites·3 claims
- 0275US10363306B2Cytokines and neuroantigens for treatment of immune disordersUNIV EAST CAROLINA·Filed 2017·Granted Jul 30, 2019·2 cites·4 claims
- 0372US9745361B2Cytokine-based fusion proteins for treatment of immune disordersUNIV EAST CAROLINA·Filed 2014·Granted Aug 29, 2017·2 cites·17 claims
- 0472US9669090B2Cytokines and neuroantigens for treatment of immune disordersUNIV EAST CAROLINA·Filed 2014·Granted Jun 6, 2017·2 cites·3 claims
- 0561US8920808B2Cytokine-based fusion proteins for treatment of multiple sclerosisMANNIE MARK D·Filed 2007·Granted Dec 30, 2014·0 cites·10 claims
- 0658US2022380728A1Compositions and methods for in vitro cultivation and/or expansion of regulatory t cellsUNIV EAST CAROLINA·Filed 2022·Application pending·0 cites
- 0757US10940200B2Aluminum based adjuvants for tolerogenic vaccinationUNIV EAST CAROLINA·Filed 2016·Granted Mar 9, 2021·0 cites·26 claims
- 0857US2024190935A1Compositions and methods of treating pathogenic infections by using fusion proteinsUNIV EAST CAROLINA·Filed 2022·Application pending·0 cites
- 0953US11384336B2Compositions and methods for in vitro cultivation and/or expansion of regulatory T cellsUNIV EAST CAROLINA·Filed 2017·Granted Jul 12, 2022·0 cites·16 claims
- 1052US2024043492A1Compositions and Methods of Treating a Coronavirus Infection By Use of an Interferon Fusion ProteinUNIV EAST CAROLINA·Filed 2021·Application pending·0 cites
- 1137US2012082644A1Cytokines and neuroantigens for treatment of immune disordersMANNIE MARK D·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark D. Mannie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →